drugset / Trial / NCT00314327
Optimizing Response in Psychosis Study
Phase 4
Terminated
1 enrolled
Northwell Health
National Alliance for Research on Schizophrenia and Depression · collabThe Zucker Hillside Hospital · collab
NaSingle-groupOpen-labelTreatment
Summary
The purpose of this project is to evaluate the efficacy of long-acting risperidone for patients with first episode schizophrenia spectrum who did not improve sufficiently with the first antipsychotic medication they tried during their initial treatment trial.
Timeline
- Start
- 2006-04
- Primary completion
- 2013-11
- Completion
- 2013-11
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Risperidone | Other / unclassified | 25 mg | Intramuscular |